Abstract
Seven sartans have been chromatographed with acetonitrile-buffer and methanol–buffer in different proportions as mobile phases. The retention values, log k or R M were extrapolated to zero organic modifier content to obtain the log k w or R MW values. Calibration equations were obtained for standards of known lipophilicity. A simple method employing a gradient procedure of 10–100% acetonitrile or methanol in 60 min and standards of the extreme lipophilicity was also elaborated. Chromatographic log P values were compared to those calculated by use of different software products. Finally, principal component analysis was performed to explore and visualize similarities and differences among the drugs and among the methods.
Similar content being viewed by others
References
Fabiani ME (1999) Curr Hypertens Rep 1:394–401. doi:10.1007/s11906-999-0054-1
Perišić-Janjić NU, Djaković-Sekulić TL, Stojanović SZ, Penov-Gaši KM (2005) Steroids 70:137–144. doi:10.1016/j.steroids.2004.11.002
Ačanski MM (2005) Chromatographia 62:475–482. doi:10.1365/s10337-005-0636-2
Argekar AP, Sawant JG (2000) Anal Lett 33:869–880. doi:10.1080/00032710008543095
Hertzog DL, McCafferty JF, Fang X, Tyrrell RJ, Reed RA (2002) J Pharm Biomed Anal 30:747–760. doi:10.1016/S0731-7085(02)00385-0
Zarapkar SS, Kanyawar NS (2002) Indian Drugs 39:338–341
Carlucci G, Di Carlo V, Mazzeo P (2000) Anal Lett 33:2491–2500. doi:10.1080/00032710008543204
Carlucci G, Di Carlo V, Mazzeo P, Quaglia MP (2000) J Pharm Biomed Anal 23:185–189. doi:10.1016/S0731-7085(00)00268-5
Dinç E, Üstündag O (2005) Chromatographia 61:237–244. doi:10.1365/s10337-005-0511-1
Kanumula GV, Raman B (2000) Indian Drugs 37:38–41
Zhao Z, Wang Q, Tsai EW, Quin XZ, Ip D (1999) J Pharm Biomed Anal 20:129–136. doi:10.1016/S0731-7085(99)00004-7
Zarghi A, Foroutan SM, Shafaati A, Khoddam A (2005) Arzneim Forsch 55:569–572
Hempen C, Gläsle-Schwarz L, Kunz U, Karst U (2006) Anal Chim Acta 560:41–49. doi:10.1016/j.aca.2005.12.035
Shah SA, Rathod IS, Suhangia BN, Sawale SS, Patel JB (2001) J AOAC Int 84:1715–1723
McCarthy KE, Wang Q, Tsai EW, Gilbert RE, Ip DP, Brooks MA (1998) J Pharm Biomed Anal 17:671–677. doi:10.1016/S0731-7085(97)00251-3
Sane RT, Francis M, Pawar S (2003) Indian Drugs 40:104–110
Tosco P, Rolando B, Fruttero R, Henchoz Y, Martel S, Carrupt PA et al (2008) Helv Chim Acta 91:468–482. doi:10.1002/hlca.200890051
Tetko IV, Gasteiger J, Todeschini R, Mauri A, Livingstone D, Ertl P et al (2005) J Comput Aided Mol Des 19:453–463. doi:10.1007/s10822-005-8694-y
Moffat AC, Osselton MD, Widdop B (2004) Clarke’s analysis of drugs and poisons in pharmaceuticals. Pharmaceutical Press, London
Soczewiński E, Wachtmeister CA (1962) J Chromatogr A 7:311–320. doi:10.1016/S0021-9673(01)86422-0
Donovan SF, Pescatore MC (2002) J Chromatogr A 952:47–61. doi:10.1016/S0021-9673(02)00064-X
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Inglot, T., Gumieniczek, A., Komsta, Ł. et al. LC and Principal Component Analysis in the Lipophilicity Study of Seven Angiotensin II-AT1 Receptor Antagonists (Sartans). Chroma 68, 977–983 (2008). https://doi.org/10.1365/s10337-008-0801-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1365/s10337-008-0801-5